Inhibition of ACADM could alter hepatocellular carcinoma cell lipid metabolism and promote cell lipid accumulation, ultimately drive hepatocarcinogenesis (Li et al., 2019). The gene discussed is ACADM; the disease is hepatocellular carcinoma.